Marie Ange Thelu

Summary

Country: USA

Publications

  1. doi request reprint Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin
    Marion Levast
    Laboratory of Virology, Grenoble University Hospital, Grenoble, France
    J Med Virol 82:747-54. 2010
  2. ncbi request reprint Lack of clinical significance of variability in the internal ribosome entry site of hepatitis C virus
    Marie Ange Thelu
    Département d Hépato Gastroentérologie, Hopital Albert Michallon, Grenoble, France
    J Med Virol 72:396-405. 2004
  3. pmc Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C
    Emilie Fugier
    INSERM, U823, Grenoble, France Université Joseph Fourier, UMR S823, Grenoble, France
    PLoS ONE 9:e95614. 2014
  4. doi request reprint Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges
    Pauline Trémeaux
    a Laboratoire de Virologie, Institut de Biologie et Pathologie, CHU Grenoble Alpes, Grenoble, France
    Crit Rev Clin Lab Sci 53:341-51. 2016
  5. doi request reprint Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis
    Nathalie Sturm
    INSERM, Unité 823, Grenoble, France
    J Hepatol 53:25-35. 2010

Collaborators

  • Patrice Morand
  • J P Zarski
  • Vincent Leroy
  • Nathalie Sturm
  • Pauline Trémeaux
  • Emilie Fugier
  • Sylvie Larrat
  • Tania Dufeu-Duchesne
  • Patrice N Marche
  • Evelyne Jouvin-Marche
  • Marion Levast
  • Michael Blum
  • Alban Caporossi
  • Zuzana Macek Jilkova
  • Nicolas Van Campenhout
  • Hélène Marche
  • Philippe Arvers
  • Guéorgui Dimitrov
  • Martine Pernollet
  • Alice Cheveau
  • Paula Bonorino
  • Muhammad Ramzan
  • Xavier Camous
  • Christiane Guillermet
  • Elisabeth Brambilla
  • Sandrine Nicod
  • Agnès Plages
  • Jean Marie Seigneurin

Detail Information

Publications5

  1. doi request reprint Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin
    Marion Levast
    Laboratory of Virology, Grenoble University Hospital, Grenoble, France
    J Med Virol 82:747-54. 2010
    ..This, just as anti-HBC status, had no clinical impact in a large cohort of hepatitis C patients. It therefore does not appear useful to screen for occult hepatitis B in these patients with this test before beginning HCV treatment...
  2. ncbi request reprint Lack of clinical significance of variability in the internal ribosome entry site of hepatitis C virus
    Marie Ange Thelu
    Département d Hépato Gastroentérologie, Hopital Albert Michallon, Grenoble, France
    J Med Virol 72:396-405. 2004
    ..Variations observed in the IRES are not a parameter of response to antiviral therapy, but the integrity of this region is a necessary condition to maintain its activity...
  3. pmc Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C
    Emilie Fugier
    INSERM, U823, Grenoble, France Université Joseph Fourier, UMR S823, Grenoble, France
    PLoS ONE 9:e95614. 2014
    ..Thus, we conclude that critical roles of IH-NK cells have to be taken into account in the course of the liver pathogenesis associated to chronic HCV infection. ..
  4. doi request reprint Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges
    Pauline Trémeaux
    a Laboratoire de Virologie, Institut de Biologie et Pathologie, CHU Grenoble Alpes, Grenoble, France
    Crit Rev Clin Lab Sci 53:341-51. 2016
    ..The progress brought by new and future technologies will also be discussed, as well as the remaining difficulties, largely due to the genomic variability. ..
  5. doi request reprint Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis
    Nathalie Sturm
    INSERM, Unité 823, Grenoble, France
    J Hepatol 53:25-35. 2010
    ..In vitro data point out that regulatory T cells (Treg) are able to suppress HCV-specific lymphocyte proliferation and cytokine secretion but their implication in this pathology is still debated...